Loading data...
Company 100
CEO
Hiroko Yamagami
Zero delayed diagnoses
Recent News & PR
Summary
Message to Participants
Detailed Information
Company 100 aims to improve the screening rate for breast cancer by providing a comfortable breast cancer examination for those who have avoided painful tests. Their goal is to promote early detection of breast cancer and eliminate delays in diagnosis.
Unfair Advantage & Strengths
N/A
Competitors
N/A
Company Profile
事業カテゴリ
Healthcare / Biotech, SaaS / B2B Software, Japan–Global / Cross-border
本社所在地
Kita-ku, Kyoto, Japan
設立日
2023/3/7
資本金
5,000万円
Employee Count
1
Industry Outlook & Trends for Company 100
Driven by aging populations and rising healthcare costs, the healthcare and biotech market where Company 100 operates is growing globally. Telemedicine, digital health via wearables, AI-driven drug discovery, and gene therapy are advancing rapidly. The industry is shifting from treatment to prevention, increasing demand for highly personalized health solutions like those developed by Company 100.
🔒
VPO Investor Pro Features
You are viewing a basic startup profile. Create a free account to access the dashboard. You can also upgrade to the "Investor Pro" plan to unlock full access to the following premium databases and features:
🎬
Elevator & Full Pitch Video
Watch full presentations with English/Japanese subtitles.
📊
AI Quick Report & Valuation
Get AI-driven assessment scores on market, product, and traction.
📅
Priority Challenges & Hiring
Access core corporate bottlenecks and current hiring plans.
📝
Full Transcripts
Read full pitch dialogue in both English and Japanese.
📈
Financials & Exit Strategy
Unlock IPO/M&A timelines and debt/equity plans.
👥
Advisors & Key Members
View internal team details and advisory board configurations.